Brief: Curevac Receives Additional Positive Validity Decision From European Patent Office In Ongoing Litigation Against Biontech SE
15/05/2025 21:12
May 15 (Reuters) - CureVac NV 5CV.DE: EQS-NEWS: CUREVAC RECEIVES ADDITIONAL POSITIVE VALIDITY DECISION FROM EUROPEAN PATENT OFFICE IN ONGOING LITIGATION AGAINST BIONTECH SE CUREVAC NV - EPO DISMISSES OPPOSITION BY BIONTECH AND PFIZER ON PATENT EP 4 023 755 B1 Source text: ID:nEQ5j1yVDa Further company coverage: 5CV.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028